Pharmacological and Non-pharmacological Treatment Effects on Children With Different Predicted Myopia Progression Rate
- Disease/Condition
- Myopia
- Drug/Device/Intervention
- Atropine 0.05%
- Study type
- Interventional
- Intervention type
- drug
- Primary sponsor
- The Hong Kong Polytechnic University
- Location
- Hong Kong, China
- Phase
- N/A
- Start date
- Jan 01, 2024
- End date
- Dec 01, 2026
- Enrollment
- 80 participants
Subjective refraction,Axial length
The goal of this clinical trial is to compare pharmacological and non-pharmacological
 treatment effects on the children with different predicted myopia progression rate measured
 by modified multifocal electroretinogram. The main questions it aims to answer are:
 
 - the effectiveness of using 0.05% atropine and prescribing DIMS lens for myopia control
 in children with different myopia progression rates
 
 - the contribution of L/M cones in juvenile myopia progression and changes of retinal
 activities under atropine and DIMS treatment.
 
 Participants will have baseline and follow-up eye examinations and given either
 pharmacological treatment with 0.05% atropine or non-pharmacological treatment with DIMS lens
 for myopia control.
 
 Researchers will compare the changes of refractive errors and axial length after different
 types of interventions and investigate the relations between the parameters of mfERG
 responses and the thicknesses of retinal layers and choroid.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06282848
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06282848 through Pure Global AI's free database. This phase not specified trial is sponsored by The Hong Kong Polytechnic University and is currently Recruiting. The study focuses on Myopia. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.